• Policy
• CDDC sets reimb standards for Inrebic Capsule
• by Lee, Tak-Sun Feb 3, 2023 05:54am

• Policy
• Introduction of online electronic sign-off from February
• by Lee, Tak-Sun Feb 2, 2023 05:48am

• Policy
• A year after Abilify 1mg was released,
• by Lee, Tak-Sun Feb 2, 2023 05:48am

• Policy
• South Korea will maintain its EU whitelist
• by Lee, Hye-Kyung Feb 1, 2023 05:54am

• Policy
• KMA·MOHW discusses essential healthcare at 1st meeting
• by Lee, Jeong-Hwan Jan 31, 2023 05:59am

• Policy
• The legislation of cold chain improvement plan is announced
• by Lee, Hye-Kyung Jan 30, 2023 05:55am

• Policy
• Price of Dutasteride has fallen to the 200 won range
• by Lee, Tak-Sun Jan 30, 2023 05:54am

• Policy
• Negotiating Erleada's price with the NHIS
• by Lee, Tak-Sun Jan 27, 2023 05:51am

• Policy
• The copyrights of Valcyte, Alvesco, & Bonviva changed
• by Lee, Tak-Sun Jan 27, 2023 05:50am

• Policy
• MFDS preannounces temporary narcotics designation of 2 drugs
• by Lee, Hye-Kyung Jan 26, 2023 06:05am